Formulation and Evaluation of Mucoadhesive Vaginal Films of Ketoconazole

Purpose: The aim of the present study was to formulate and evaluate mucoadhesive films containing Ketoconazole (KT) for the treatment of vaginal infections. Method: The vaginal films were made by solvent casting technique with different ratios of chitosan as mucoadhesive polymer. The prepared films were evaluated for their weight uniformity, thickness uniformity, drug content, folding endurance, in vitro diffusion, in vitro mucoadhesion study, in vitro dissolution and accelerated stability studies at 40 o ± 2 o /75% ± 5% for three months. Results: Compatibility studies by FTIR showed that there was no significant interaction between drug and polymer used. The weight of films was found to be between 1.03 g to 2.47 g. The thickness of films ranged between 0.15 mm to 0.32 mm. The drug content was found to be between 80.5% to 93.7% w/w. The folding endurance of films was found to be between 72.6 and 175.66. Mucoadhesive strength of films ranged between 17.45 g to 26.72 g. F4 was selected as the best formulation based on the evaluation studies and it showed zero order release. Conclusion: Based on the in vitro results it was concluded that the mucoadhesive films prepared with chitosan can be used as controlled drug delivery system and frequency of drug administration can be minimized leading to better patient compliance.

[1]  P. Ding,et al.  The development of polycarbophil as a bioadhesive material in pharmacy , 2013 .

[2]  R. Deveswaran,et al.  Development of bioadhesive controlled release ketoconazole vaginal films , 2012 .

[3]  Rahamatullah Shaikh,et al.  Mucoadhesive drug delivery systems , 2011, Journal of pharmacy & bioallied sciences.

[4]  Zulkar N. K. Mohammed,et al.  Mucoadhesive drug delivery system: An overview , 2010, Journal of advanced pharmaceutical technology & research.

[5]  A. Bernkop‐Schnürch,et al.  Strategies to prolong the intravaginal residence time of drug delivery systems. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[6]  R. Mashru,et al.  A Novel Itraconazole Bioadhesive Film for Vaginal Delivery: Design, Optimization, and Physicodynamic Characterization , 2009, AAPS PharmSciTech.

[7]  J. das Neves,et al.  Gels as vaginal drug delivery systems. , 2006, International journal of pharmaceutics.

[8]  F. Ahsan,et al.  The vagina as a route for systemic drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[9]  S. K. Ghosal,et al.  Design and characterization of mucoadhesive buccal patches of salbutamol sulphate. , 2004, Acta poloniae pharmaceutica.

[10]  Garg,et al.  The scope and potential of vaginal drug delivery. , 2000, Pharmaceutical science & technology today.

[11]  Y. Huang,et al.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[12]  N. Škalko-Basnet,et al.  Liposomes containing drugs for treatment of vaginal infections. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  Javed Ali,et al.  Mucoadhesive Drug Delivery Systems , 1997 .